Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Off-radar microcap Rexahn Pharmaceuticals (RNN) is up another +16.6% today, having doubled since...

  • Friday, July 6, 2012, 1:15 PM ET
    Off-radar microcap Rexahn Pharmaceuticals (RNN) is up another +16.6% today, having doubled since Monday's announcement that it's submitted an IND application to the FDA for a first-in-human study of RX-5902 to treat advanced or metastatic solid tumors.
Track new comments on this story

This news story has 4 comments:

  •  
    Well, we will see what happens next...
    6 Jul 2012, 02:14 PM Reply Like
  •  
    We will see what happens... Oncology though is a huge attraction and a compex therapeutic area but definitely the wave of the future in pharma/biotech..
    6 Jul 2012, 02:15 PM Reply Like
  •  
    I have held these shares for nearly a year now, and am solidly in the black. If you go deep on this company, their research and drug candidate is most impressive. Could be this is the next 10 bagger.
    7 Jul 2012, 01:55 PM Reply Like
  •  
    How much debt does this company have? It doesn't appear to have made any money. Maybe I just don't where to look. I will continue to research this.
    11 Jul 2012, 01:08 PM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »